A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening

Background: The fluoropyrimidine anticancer drug, especially 5- fluorouracil (5-FU) and its prodrug capecitabine are still being the backbone of chemotherapeutic regimens for colorectal cancer. Dihydropyrimidine dehydrogenase (DPD) is the crucial enzyme in the catabolism of 5-FU. Over the past 30 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Chi C., Lam, Ching W., Lam, Ka O., Lee, Victor H. F., Luk, Mai-Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066555/
https://www.ncbi.nlm.nih.gov/pubmed/30087856
http://dx.doi.org/10.3389/fonc.2018.00279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066555/
https://www.ncbi.nlm.nih.gov/pubmed/30087856
http://dx.doi.org/10.3389/fonc.2018.00279

Ejemplares similares